Intellectual property | Science and Enterprise

A company developing a system with artificial intelligence to analyze medical literature for treatment insights is… https://t.co/TdK2vtumZo
about 11 hours ago
New post on Science and Enterprise: Medical Knowledge A.I. Company Raises Early $4.8M https://t.co/lqYHuWQs7g #Science #Business
about 11 hours ago
New contributed post on Science and Enterprise: https://t.co/3Gofb2uiDv Guidelines for Training New Employees
about 14 hours ago
Regenstrief Institute, affiliated with Indiana University, is investing in a new company aiming to improve long-ter… https://t.co/87KTKEoWp8
about 15 hours ago
New post on Science and Enterprise: Institute Invests in Elderly Care Start-Up https://t.co/mCNnAqV9yY #Science #Business
about 15 hours ago

FDA Tags Biofilm Disruption Device as Breakthrough

By Alan, on October 22nd, 2019%

A system using an electric current to break up bacterial communities on orthopedic implants received a breakthrough-device designation from the Food and Drug Administration. . . . → Read More: FDA Tags Biofilm Disruption Device as Breakthrough

Trial Shows Nanotech Drug Induces Gluten Tolerance

By Alan, on October 22nd, 2019%

Results from a clinical trial show an experimental treatment encourages immune-system tolerance of gluten, preventing intestinal damage from celiac disease. . . . → Read More: Trial Shows Nanotech Drug Induces Gluten Tolerance

Merck Gaining Gut Microbe Technology for Vaccines

By Alan, on October 8th, 2019%

Drug maker Merck & Co. is partnering with a developer of treatments for disease derived from microbes in the gut, for discovery of up to three vaccines. . . . → Read More: Merck Gaining Gut Microbe Technology for Vaccines

Biotech Developing Genome-Adjusting Disease Treatments

By Alan, on September 23rd, 2019%

A new biotechnology enterprise is creating disease treatments that address regions in the genome precisely regulating expression of proteins. . . . → Read More: Biotech Developing Genome-Adjusting Disease Treatments

Start-Up Targets Extra DNA in Cancer, Raises $46.4M

By Alan, on September 19th, 2019%

A new biotechnology enterprise is developing treatments for aggressive solid tumor cancers that block the effects of DNA residing outside of chromosomes. . . . → Read More: Start-Up Targets Extra DNA in Cancer, Raises $46.4M

Spin-Off Licensing Athletic Microbiome Technology

By Alan, on September 5th, 2019%

A company spun-off from biomedical engineering labs at Harvard University is acquiring research on microbial communities in elite athletes to create new probiotics. . . . → Read More: Spin-Off Licensing Athletic Microbiome Technology

Infographic – IBM Leads Again in Patent Awards

By Alan, on August 17th, 2019%

Statista prepared a chart this week with data from an annual report by the Intellectual Property Owners Association, this weekend’s infographic on Science & Enterprise. . . . → Read More: Infographic – IBM Leads Again in Patent Awards

Company Forms to Treat Vaginal Microbial Disorders

By Alan, on August 6th, 2019%

A new enterprise has launched to develop live microbial treatments for urinary tract infections and other diseases originating in vaginal bacterial communities. . . . → Read More: Company Forms to Treat Vaginal Microbial Disorders

A.I. Helps Visualize Emergency Social Media Data

By Alan, on July 18th, 2019%

A set of computational tools developed at Purdue University enables public safety agencies to monitor potentially catastrophic events in real time by analyzing text and images on social media. . . . → Read More: A.I. Helps Visualize Emergency Social Media Data

Hearing Loss Cell Therapy Licensed in $625M Deal

By Alan, on July 18th, 2019%

A biotechnology company developing regenerative treatments for various disorders is licensing its lead therapy candidate for hearing loss to Astellas Pharma. . . . → Read More: Hearing Loss Cell Therapy Licensed in $625M Deal

Science & Enterprise subscription

Specials

Follow us on Twitter

Guest Posts

Please share Science & Enterprise